Michael Edward Pollack
Medical Practice in Wilmington, DE
License number
Delaware C7-0002090
Issued Date
Nov 27, 2000
Expiration Date
Mar 31, 2001
Category
Medical Practice
Type
ACGME Training
Address
Address
2
Wilmington, DE 19899
Personal information
See more information about Michael Edward Pollack at radaris.comName
Address
Phone
107 Creekmont Ct, Newark, DE 19702
Professional information
See more information about Michael Edward Pollack at trustoria.com
Associate Director, Health Plan Research At Healthcore, Inc.
Associate Director, Health Plan Research At Healthcore, Inc.
Position:
Associate Director, Payer and Provider Research (PPR) at HealthCore, Inc.
Location:
Greater Philadelphia Area
Industry:
Pharmaceuticals
Work:
HealthCore, Inc.
- Wilmington, Delaware since Jan 2012
-
Associate Director, Payer and Provider Research (PPR)
AstraZeneca
- Wilmington, DE Sep 2010 - Jan 2012
-
Brand Forecasting Manager, Diabetes
AstraZeneca
- Wilmington, Delaware Nov 2007 - Sep 2010
-
Associate Director, Health Economics and Outcomes Research
HealthCore, Inc.
- Wilmington, Delaware 2005 - 2007
-
Outcomes Research Manager/Sr. Research Analyst
ValueMedics, LLC
- Alexandria, VA 2002 - 2005
-
Health Economic Analyst
Education:
University of Delaware - Lerner College of Business and Economics 2000 - 2002
Masters, Economics University of Delaware - Lerner College of Business and Economics 1996 - 2000
BA, Economics/Political Science
Masters, Economics University of Delaware - Lerner College of Business and Economics 1996 - 2000
BA, Economics/Political Science
Awards:
Impact/Values in Action Award
HealthCore/WellPoint
Received 1Q2013 impact award for work performed to support WellPoint's participation in Stanford University's American Idol's in Medicine program and nomination process
Impact/Values in Action Award
HealthCore/WellPoint
Received 1Q2013 impact award for work performed to support HealthCore's development of a MicroStrategy-based research user interface that produces customized reports to pharmaceutical clients for ACS and type 2 diabetes
Bravo Award
Diabetes Team- AstraZeneca
Received “Bravo” award (March, 2011) for managing launch forecast for Kombiglyze XR. "With the excellent KXR performance the first weeks of launch, decisions needed to be made to adjust manufacturing to support the strong launch. Mike took the problem head on, considering a dizzying number of approaches to estimating continued performance of KXR to provide guidance to brand leadership."
Impact Award
HealthCore/WellPoint
Received third quarter 2006 HealthCore/WellPoint Impact award for managing a highly complex project that involved integrating new data sources, creating statistical coding and designing a physician profiling system for use by Workers Compensation clients in California.
Impact Award
HealthCore/WellPoint
Received first quarter 2005 HealthCore/WellPoint Impact Award within two months of beginning current position by demonstrating “the ability to make decisions and exercise good judgment in situations where methodologies and precedents are frequently not available.”
Player of the Month
Diabetes Team- AstraZeneca
Received ‘Player of the Month (December 2009)’ honor for publication of manuscript in Diabetes Research and Clinical Practice. Manuscript was accepted by the journal without comments.
High-Quality Peer Review
JMCP
Received ‘High-Quality Peer Review’ letter from Journal of Managed Care Pharmacy for the high-quality review work performed. Approximately 15% of reviews each year are judged as high quality.
HealthCore/WellPoint
Received 1Q2013 impact award for work performed to support WellPoint's participation in Stanford University's American Idol's in Medicine program and nomination process
Impact/Values in Action Award
HealthCore/WellPoint
Received 1Q2013 impact award for work performed to support HealthCore's development of a MicroStrategy-based research user interface that produces customized reports to pharmaceutical clients for ACS and type 2 diabetes
Bravo Award
Diabetes Team- AstraZeneca
Received “Bravo” award (March, 2011) for managing launch forecast for Kombiglyze XR. "With the excellent KXR performance the first weeks of launch, decisions needed to be made to adjust manufacturing to support the strong launch. Mike took the problem head on, considering a dizzying number of approaches to estimating continued performance of KXR to provide guidance to brand leadership."
Impact Award
HealthCore/WellPoint
Received third quarter 2006 HealthCore/WellPoint Impact award for managing a highly complex project that involved integrating new data sources, creating statistical coding and designing a physician profiling system for use by Workers Compensation clients in California.
Impact Award
HealthCore/WellPoint
Received first quarter 2005 HealthCore/WellPoint Impact Award within two months of beginning current position by demonstrating “the ability to make decisions and exercise good judgment in situations where methodologies and precedents are frequently not available.”
Player of the Month
Diabetes Team- AstraZeneca
Received ‘Player of the Month (December 2009)’ honor for publication of manuscript in Diabetes Research and Clinical Practice. Manuscript was accepted by the journal without comments.
High-Quality Peer Review
JMCP
Received ‘High-Quality Peer Review’ letter from Journal of Managed Care Pharmacy for the high-quality review work performed. Approximately 15% of reviews each year are judged as high quality.